Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy

Europace. 2014 Mar;16(3):363-71. doi: 10.1093/europace/eut339. Epub 2013 Nov 4.

Abstract

Aims: To evaluate the long-term changes of clinical and echocardiographic parameters, the incidence of cardiac events and parameters associated with late cardiac events in 'super-responders' to cardiac resynchronization therapy (CRT) with [CRT defibrillator (CRT-D)] or without defibrillator back-up.

Methods and results: In all consecutive patients treated with CRT in two Italian centres (Trieste and Udine) with left ventricular ejection fraction (LVEF) ≤0.35 at implantation (Timp) and LVEF > 0.50 1 and/or 2 years (Tnorm) after implantation, the long-term outcome and the evolution of echocardiographic parameters were assessed; factors associated with a higher risk of cardiac events, defined as hospitalization or death for heart failure (HF), sudden death, or CRT-D appropriate interventions, were also analysed. Among the 259 patients evaluated, 62 (24%) had LVEF ≥ 0.50 at Tnorm (n = 44 with at 1 year, n = 18 at 2 years). During a mean follow-up of 68 ± 30 months, one cardiac death (for HF) and eight cardiovascular events (two hospitalization for HF and six appropriate CRT-D interventions) occurred. At the last echo evaluation (Tfup) performed 51 ± 26 months after Timp, LVEF was <0.50 in five patients (>0.45 in four of them). At univariable analysis, only LV end-systolic volume evaluated at Tfup was associated with a higher risk of cardiac events during follow-up.

Conclusion: In 'super-responders' to CRT long-term outcome is excellent. However, cardiac events, mainly CRT-D appropriate interventions, can occur despite the persistence of LVEF > 0.50. Early identification of these patients is still an unsolved issue.

Keywords: Cardiac resynchronization therapy; Heart failure; Outcome; Super-responders.

Publication types

  • Controlled Clinical Trial
  • Multicenter Study

MeSH terms

  • Aged
  • Cardiac Resynchronization Therapy / mortality*
  • Combined Modality Therapy
  • Comorbidity
  • Death, Sudden, Cardiac / epidemiology*
  • Death, Sudden, Cardiac / prevention & control
  • Defibrillators, Implantable / statistics & numerical data*
  • Female
  • Heart Failure / mortality*
  • Heart Failure / prevention & control*
  • Hospital Mortality*
  • Humans
  • Italy
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Prevalence
  • Prognosis
  • Risk Factors
  • Treatment Outcome